Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The FDA said Chantix and Zyban will carry the warnings to alert consumers to the risks of depression and suicidal thoughts when using the drugs. The drugs also have been reported to cause changes in behavior, hostility and agitation in users, whether users had a history of psychiatric illness or not. In many cases, side effects started shortly after use began and ended when the medication was stopped.

   

Today in Popular Press...keeping you current

Cancer survival disparities for most minority populations increase as cancers become more treatable
EurekAlert, 12/18/09

Antidepressants cut risk of hospital readmission for suicidal youth, study suggests
ScienceDaily, 12/18/09

Strict blood sugar control in some diabetics does not lower heart attack, stroke risk
ScienceDaily, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address